Out of stock

This item is currently unavailable

Gone for 137 days. Could come back at any time — we're watching for you.

Out of stock 137 days · last price £90

Wiley Novel Infectious Agents and the Central Nervous System (Novartis Foundation Symposia)

Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 696 days · 696 data points (no recent data)

Historical
Generating forecast…
£90.00 £85.50 £87.30 £89.10 £90.90 £92.70 £94.50 23 October 2024 14 April 2025 05 October 2025 28 March 2026 18 September 2026
View at Amazon ↗
Out of stock

Price data last checked 35 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 696 days • 1 price levels

Days at Price
696 days 0 174 348 522 696 £90 Days at Price

Price Analysis

Most common price: £90 (696 days, 100.0%)

Price range: £90 - £90

Price levels: 1 different prices over 696 days

Description

Novel Infectious Agents and the Central Nervous System Chairman: F. Brown 1988 Certain neurological disorders, such as Creutzfeldt-Jakob disease, are clearly caused by an infectious agent, but the nature of this agent has yet to be determined. Scrapie is a disease of sheep that shows the same properties as these rare but fatal human diseases. A cardinal feature of the disorders is the exceptionally long incubation period, which makes investigation of the causative agent a long-term and costly process. Studies have been greatly facilitated by the experimental transmission of scrapie to rodents, and the isolation of strains of scrapie that have relatively short incubations. The elusive nature of the scrapie agent (it is extremely resistant to normal physicochemical methods of inactivation) has meant that numerous hypotheses have been proposed for its structure. The basic issue is whether it contains a genome encoding sufficient information to direct its own replication, and the nature of this putative informational molecule. This book presents the latest results on scrapie, including classical genetic studies, characterization of the major protein found in scrapie-associated fibrils, and experiments using the cloning and gene transfer techniques of molecular biology. The implications of the findings from animal studies for understanding the human disorders are explored, and the neuropathology in both animals and humans is described. There is also a report on the epidemiology of the human diseases, and a discussion of the various features shared by these infectious neurological disorders and Alzheimer's disease. Recent Ciba Foundation books: No 126 Selective neuronal death Chairman: H. Wisniewski ISBN 0 471 91092 9 No 128 Novel diarrhoea viruses Chairman: R. F. Bishop ISBN 0 471 91094 5 No 129 Autoimmunity and autoimmune disease Chairman: D. K. Peters ISBN 0 471 91095 3 No 130 Molecular approaches to human polygenic disease Chairman: D. J. Weatherall ISBN 0 471 91096 1

Product Specifications

Brand
Wiley
Format
hardcover
Domain
Amazon UK
Release Date
30 March 1988
Listed Since
09 February 2007

Barcode

No barcode data available

Similar Products You Might Like

Neuronal Cell Death: Methods and Protocols: 1254 (Methods in Molecular Biology, 1254)
96% match

Neuronal Cell Death: Methods and Protocols: 1254 (Methods in Molecular Biology, 1254)

Humana

£79.93 24 Sep 2026
Cancer Immunotherapy Volume 164 - Progress in Molecular Biology
96% match

Cancer Immunotherapy Volume 164 - Progress in Molecular Biology

Elsevier

£133.99 07 Oct 2026
Autophagy Dysfunction in Alzheimer's Disease and Dementia
96% match

Autophagy Dysfunction in Alzheimer's Disease and Dementia

Elsevier

£114.99 05 Oct 2026
Neurodegenerative Disorders as Systemic Diseases
96% match

Neurodegenerative Disorders as Systemic Diseases

Springer

£107.85 23 Sep 2026
Brain Imaging: Volume 165 (Progress in Molecular Biology and Translational Science, Volume 165)
96% match

Brain Imaging: Volume 165 (Progress in Molecular Biology and Translational Science, Volume 165)

Elsevier

£128.99 25 Sep 2026
Neurodegenerative Diseases: Pathology, Mechanisms, and Potential Therapeutic Targets: 15 (Advances in Neurobiology, 15)
96% match

Neurodegenerative Diseases: Pathology, Mechanisms, and Potential Therapeutic Targets: 15 (Advances in Neurobiology, 15)

Springer

£202.21 18 Aug 2026
Immunotherapy and Biomarkers in Neurodegenerative Disorders (Methods in Pharmacology and Toxicology)
96% match

Immunotherapy and Biomarkers in Neurodegenerative Disorders (Methods in Pharmacology and Toxicology)

Humana

£99.94 06 Oct 2026
Molecular Biology of Neurodegenerative Diseases (Progress in Molecular Biology and Translational Science): Volume 107
96% match

Molecular Biology of Neurodegenerative Diseases (Progress in Molecular Biology and Translational Science): Volume 107

Elsevier

£92.99 24 Sep 2026
A Review on Diverse Neurological Disorders: Pathophysiology, Molecular Mechanisms, and Therapeutics
96% match

A Review on Diverse Neurological Disorders: Pathophysiology, Molecular Mechanisms, and Therapeutics

Elsevier

£158.99 23 Sep 2026
Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers
96% match

Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers

Springer

£105.50 24 Sep 2026
Neuron-Glia Interaction in Neuroinflammation - Advances in Neurobiology
96% match

Neuron-Glia Interaction in Neuroinflammation - Advances in Neurobiology

Springer

£129.23 08 Oct 2026
Mitochondrial Neuropathies: Volume 145 (International Review of Neurobiology, Volume 145)
96% match

Mitochondrial Neuropathies: Volume 145 (International Review of Neurobiology, Volume 145)

Elsevier

£133.99 07 Sep 2026
Movement Disorders Curricula
96% match

Movement Disorders Curricula

Springer

Price unavailable
Neurodegenerative Diseases: Molecular and Cellular Mechanisms and Therapeutic Advances (Gwumc Department of Biochemistry and Molecular Biology Annual Spring Symposia)
96% match

Neurodegenerative Diseases: Molecular and Cellular Mechanisms and Therapeutic Advances (Gwumc Department of Biochemistry and Molecular Biology Annual Spring Symposia)

Springer

£140.42 06 Oct 2026
Molecular Biology of Neurodegenerative Diseases: Visions for the Future - Part B (Volume 177) (Progress in Molecular Biology and Translational Science, Volume 177)
96% match

Molecular Biology of Neurodegenerative Diseases: Visions for the Future - Part B (Volume 177) (Progress in Molecular Biology and Translational Science, Volume 177)

Elsevier

£79.99 25 Sep 2026
Academic Press Molecular Biology of Neurodegenerative Diseases
96% match

Academic Press Molecular Biology of Neurodegenerative Diseases

Elsevier

£133.99 07 Oct 2026
NMDA Receptors: Methods and Protocols - Research Guide
96% match

NMDA Receptors: Methods and Protocols - Research Guide

Humana

£109.90 06 Oct 2026
Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders (International Society of Neuropathology Series)
96% match

Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders (International Society of Neuropathology Series)

Wiley

£181.99 18 Aug 2026
Neurodegenerative Diseases: Unifying Principles
96% match

Neurodegenerative Diseases: Unifying Principles

Oxford University Press

£132.46 30 Sep 2026
Molecular Neurovirology: Viral CNS Infections - Humana
96% match

Molecular Neurovirology: Viral CNS Infections - Humana

Humana

£91.36 07 Oct 2026
Cerebrospinal Fluid Biomarkers: 168 (Neuromethods, 168)
96% match

Cerebrospinal Fluid Biomarkers: 168 (Neuromethods, 168)

Humana

£140.56 21 Aug 2026
Biomarkers for Alzheimer’s Disease Drug Development: 1750 (Methods in Molecular Biology, 1750)
96% match

Biomarkers for Alzheimer’s Disease Drug Development: 1750 (Methods in Molecular Biology, 1750)

Humana

£81.54 30 Sep 2026
Protein Misfolding in Neurodegenerative Diseases: Mechanisms and Therapeutic Strategies (CRC Enzyme Inhibitors)
96% match

Protein Misfolding in Neurodegenerative Diseases: Mechanisms and Therapeutic Strategies (CRC Enzyme Inhibitors)

CRC Press

£225.26 18 Aug 2026
Neurobiology of Disease
96% match

Neurobiology of Disease

Elsevier

£162.38 19 Aug 2026